<< Back to the News

.

Published on 26.02.2018

Please see below a message from Andrew McLean, CEO, Sirtex:
On January 30th, Sirtex Medical Limited signed an agreement to be acquired by Varian, a global leader in radiation medicine: https://sirtex.com/ap/investors/proposed-varian-acquisition-of-sirtex
 
The long-term goal of the acquisition is to maximize synergies with a well-resourced, innovative global market leader to address the expanding needs of the Interventional Radiology community.  Our companies share a vision centered on fighting cancer, and we believe the combination will accelerate innovation in the field of Interventional Oncology. 
 
Varian is committed to serving Sirtex’ physician partners with the same level of excellence that it brings to the Radiation Oncology space.  Varian plans to make Sirtex, and SIR-Spheres® Y-90 resin microspheres, the cornerstone of a new, dedicated Interventional Oncology business unit.   We are excited about the technologies that Varian has already been exploring which complement Sirtex’ long-standing focus on liver directed therapies, specifically in the area of optimizing imaging analytics. 
 
Importantly, it remains clear to all of us in this proposed combination, that the referral network, procedure planning, treatment delivery, and patient monitoring will continue to be the unique domain of the Interventional Radiology community.
 
Varian and Sirtex are currently collaborating on the integration of our two global organizations, and it is anticipated that this process will be completed by June 2018.  In the meantime, Sirtex will remain focused on providing physicians, and most importantly, the patients we serve, the best-in-class service you have come to expect from the Sirtex Team. 
 
We will continue to engage with you, our valued physician partners, on how we can more broadly serve your needs, both today, and in the future.
 
To learn more about Varian, you may find it helpful to listen to the webcast from their CEO, Dow Wilson, announcing the pending acquisition: http://investors.varian.com/presentations